Ulta Beauty Earnings Show Sales Strength, EPS Slip

Ulta Beauty earnings showed fourth quarter sales strength and an EPS decline, prompting traders to refocus on margin pressure, capex and share repurchases.

March 12, 2026·2 min read
View all news articles
Flat vector cosmetics display under dimming light representing Ulta Beauty earnings focus on sales and margins.

KEY TAKEAWAYS

  • Q4 net sales were $3.9 billion, with comparable sales rising 5.8%.
  • Diluted EPS fell to $8.01 and operating margin compressed to 12.2%.
  • Fiscal 2026 guidance calls for 6% to 7% sales growth, shifting scrutiny to margins and capital allocation.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Ulta Beauty (ULTA) reported earnings on March 12, 2026, showing sales strength alongside a decline in diluted earnings per share (EPS). The company issued fiscal 2026 guidance projecting slower growth, shifting investor focus to margins and capital allocation.

Quarterly and Full-Year Results

Ulta Beauty posted fourth-quarter 2025 net sales of $3.9 billion, up 11.8% year over year. Comparable sales rose 5.8%, driven by a 4.2% increase in average ticket size and a 1.6% rise in transactions. Diluted EPS fell to $8.01 from $8.46 a year earlier. Operating income totaled $476.9 million, or 12.2% of net sales, down from a 14.8% margin in the prior year. Gross profit was $1.5 billion, representing 38.1% of net sales.

Selling, general, and administrative expenses increased 23.0% to $1.0 billion, or 25.7% of net sales, up from 23.4% in the year-ago quarter. The company attributed the rise to higher advertising costs, corporate overhead, and incentive compensation.

For fiscal 2025, Ulta Beauty recorded net sales of $12.4 billion, a 9.7% increase from the prior year, with comparable sales growth of 5.4%. Diluted EPS rose 1.2% to $25.64, while operating income declined to $1.5 billion, or 12.4% of net sales, from 13.9% the previous year. Kecia Steelman, president and CEO, said, "The Ulta Beauty team closed the year with momentum, delivering strong fourth quarter and full-year sales and continued market share gains."

Fiscal 2026 Guidance and Capital Allocation

The company forecasted fiscal 2026 net sales growth of 6% to 7%, comparable sales growth of 2.5% to 3.5%, and operating income growth of 6% to 9%. Diluted EPS is projected between $28.05 and $28.55. Capital expenditures are expected to range from $400 million to $450 million. The guidance is based on current estimates and highlights risks including consumer-spending volatility, tariffs, and geopolitical events.

As of Jan. 31, 2026, Ulta Beauty held $424.2 million in cash and $2.2 billion in inventories, a 10.8% increase attributed to new brands, the Space NK acquisition, and about 60 net new stores. Fiscal 2025 capital spending totaled $434.8 million.

Share repurchases resumed, with 2.0 million shares bought back for $890.5 million. The company has $1.8 billion remaining under a $3.0 billion authorization. The fiscal 2025 product mix consisted of 38% cosmetics, 24% skincare and wellness, 19% haircare, 13% fragrance, 4% services, and 2% other categories.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Kevin Warsh Fed Chair Advances After Committee Vote

Kevin Warsh Fed Chair Advances After Committee Vote

Kevin Warsh Fed chair nomination advanced from committee to the full Senate, making confirmation timing a near-term market variable ahead of the June FOMC.

Uber Hotel Bookings Expand With Expedia Partnership

Uber Hotel Bookings Expand With Expedia Partnership

Uber hotel bookings with Expedia and AI features add in-app lodging and Uber One credits, strengthening membership monetization and cross-sell signals.

Microsoft Earnings Preview: Azure and AI

Microsoft Earnings Preview: Azure and AI

Microsoft earnings preview puts focus on Azure growth and elevated AI CapEx and the $81.4 billion revenue consensus for margin and flow cues.

Pershing Square IPO Debuts on NYSE

Pershing Square IPO Debuts on NYSE

Pershing Square IPO began trading on April 29, 2026, raising $5.0 billion and adding listed supply that will affect conversion mechanics and liquidity.

KONE to Acquire TK Elevator

KONE to Acquire TK Elevator

KONE to Acquire TK Elevator; investors will watch governance, financing and regulatory timing as the cash-and-stock deal targets synergies before Q2 2027.

AstraZeneca Q1 Results Beat on Oncology Strength

AstraZeneca Q1 Results Beat on Oncology Strength

AstraZeneca Q1 results showed oncology and rare-disease revenue lifted profit and core EPS and should influence near-term investor positioning on guidance